CoChat

Impaired brain insulin signalling in Parkinson's disease

Bassil, Fares, Delamarre, Anna, Canron, Marie‐Hélène, Dutheil, Nathalie, Vital, Anne, Négrier‐Leibreich, Marie‐Laure, Bezard, Erwan, Fernagut, Pierre‐Olivier, Meissner, Wassilios G. · 2022 · Neuropathology and Applied Neurobiology
Cited by 73

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Aims: Brain insulin resistance (i.e., decreased insulin/insulin‐like growth factor‐1 [IGF‐1] signalling) may play a role in the pathophysiology of Parkinson's disease (PD), and several anti‐diabetic drugs have entred clinical development to evaluate their potential disease‐modifying properties in PD. A measure of insulin resistance is the amount of the downstream messenger insulin receptor substrate‐1 that is phosphorylated at serine residues 312 (IRS‐1pS312) or 616 (IRS‐1pS616). We assessed IRS‐1pS312 and IRS‐1pS616 expression in post‐mortem brain tissue of PD patients and a preclinical rat model based on viral‐mediated expression of A53T mutated human α‐synuclein (AAV2/9‐h‐α‐synA53T). Methods: IRS‐1pS312 and IRS‐1pS616 staining intensity were determined by immunofluorescence in both neurons and glial cells in the substantia nigra pars compacta (SNc) and putamen of PD patients and controls without known brain disease. We further explored a possible relation between α‐synuclein aggregates and brain insulin resistance in PD patients. Both insulin resistance markers were also measured in the SNc and striatum of AAV2/9‐h‐α‐synA53T rats. Results: We found higher IRS‐1pS312 staining intensity in nigral dopaminergic neurons and a trend for higher IRS‐1pS312 staining intensity in putaminal neurons of PD patients. We observed no differences for IRS‐1pS616 staining intensity in neurons or IRS‐1pS312 staining intensity in glial cells. IRS‐1pS312 showed high co‐localisation within the core of nigral Lewy bodies. Like PD patients, AAV2/9‐h‐α‐synA53T rats showed higher IRS‐1pS312 staining intensity in the SNc and striatum than controls, whereas IRS‐1pS616 was not different between groups. Conclusions: Our results provide evidence for brain insulin resistance in PD and support the rationale for repurposing anti‐diabetic drugs for PD treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/nan.12760

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 73

Metadata

Authors
Bassil, F., Delamarre, A., Canron, M., Dutheil, N., Vital, A., Négrier‐Leibreich, M., Bezard, E., Fernagut, P., & Meissner, W. G.
Venue
Neuropathology and Applied Neurobiology
Publisher
Wiley
Published
2021-09-13
Volume
48
Issue
1
Pages
e12760-e12760
ISSN
  • 0305-1846 (ISSN-L)
  • 1365-2990
OpenAlex
W3195130648
Cited by
73
References
11
FWCI
4.33
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impaired brain insulin signalling in Parkinson's disease. https://app.cochat.ai/papers/10.1111/nan.12760
The paper
Bassil, F., Delamarre, A., Canron, M., Dutheil, N., Vital, A., Négrier‐Leibreich, M., Bezard, E., Fernagut, P., & Meissner, W. G. (2022). Impaired brain insulin signalling in Parkinson's disease. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.12760

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.